PCMA Supports E-Prescribing Legislation to Combat Opioid Crisis
April 25, 2018
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement on the House Energy and Commerce Health...
Filter by:
Choose a Topic
Filter by Year:Clear Filters- Press Releases
- Biosimilars
- Drug Abuse Prevention
- Drug Adherence Programs
- Drug Cost Management
- Drug Coupons & Assistance Programs
- Drug Coverage Mandates
- Drug Price Negotiations & Rebates
- Employers, Unions, & Insurers
- FEHBP Program
- Formulary Design
- Fraud, Waste, & Abuse
- Generic Drug Utilization
- Health Insurance Marketplace (ACA)
- Home Delivery of Drugs
- Mark Merritt
- Medicaid
- Medicare Part D
- Patient Cost Sharing
- Pharmacy Networks
- Pharmacy Reimbursement & Contracting
- REMS Management
- Specialty Benefit Design
- Specialty Pharmacies
- Specialty Pharmacy Networks
- TRICARE
- Value & Outcomes-Based Contracting
PCMA: New IQVIA Institute Report Shows Declining Net Spending on Prescription Drugs
April 19, 2018
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement on a new report from the IQVIA...
PCMA “PBM Policy Forum” Addresses Federal and State Drug Pricing Issues
April 18, 2018
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) will hold its annual “PBM Policy Forum” tomorrow, April 19, at...
April 11, 2018
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt released the following statement on the House...
Independent Drugstore Lobby Agenda Raises Government Costs, Increases Deficit
April 10, 2018
(Washington, D.C.) — As the independent drugstore lobby descends on Capitol Hill this week to push for costly new government health...
April 03, 2018
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt released the following statement on the Medicare...
PCMA Response to FDA Commissioner Scott Gottlieb’s Remarks on the Drug Supply Chain
March 28, 2018
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement on today’s remarks by Food and Drug...
PCMA Responds to “Patient Right to Know Drug Prices Act” and “Know the Lowest Price Act”
March 15, 2018
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement on legislation, the “Patient Right to Know...
Outlier Legislation Raises Costs for Arkansas Taxpayers and Employers
March 15, 2018
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt released the following statement on Arkansas legislation,...
PCMA: New IQVIA Institute Report Shows PBM Tools Reduce Drug Spending
March 13, 2018
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement on a new report from IQVIA Institute...
PCMA Response to FDA Commissioner Scott Gottlieb’s Remarks on Biosimilars
March 07, 2018
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following response to this morning’s remarks by Food and...
PCMA Supports Bipartisan E-Prescribing Legislation to Combat Opioid Epidemic
February 27, 2018
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) issued the following statement on bipartisan Senate companion legislation (Every Prescription...